Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal

The Scan

Not Counting These

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Caputo on Leave

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

The Timing of a Vaccine

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

Nature Papers Report on Mass Spec Repository, Tumor Signaling Maps, Viking Genetics

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.

Menu

Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal

To read the full story....

Breaking News

CRISPR-Chip Maker Cardea Bio Raises $7.5M in First Close of Series A2 Financing Round

Qiagen Acquires Remaining Stake in NeuMoDx Molecular for $248M

New York City Opening Dedicated COVID-19 Testing Laboratory

Willingness to Donate DNA to Research Is Low, Global Survey Finds

Adrenal Neuroblastoma Cell Features Found by Single-Cell Transcriptome Sequencing

Scipher Medicine Taps Ambry Genetics to Scale Up TNF Inhibitor Response Test

Recent Headlines from
Precision Oncology News

Pfizer Pursuing Multiple Biomarker-Defined Cancer Indications in Coming Years

COVID-19 Experience Spurs Cancer Research Community to Embrace Telemedicine-Enabled Trials

Immatics Advancing T-Cell Receptor Therapies for Solid Cancers at European, US Study Sites

T-Cell Immunotherapy Targeting AML With CBFB-MYH11 Fusions Headed for Human Studies

Relaunched Canadian BRCA1/2 Screening Project Aims to ID High-Risk Carriers, Intervene Early

The Scan

Not Counting These

Caputo on Leave

The Timing of a Vaccine

Nature Papers Report on Mass Spec Repository, Tumor Signaling Maps, Viking Genetics

What's Popular?

Roche Gets FDA Emergency Use Authorization for Rapid Coronavirus, Flu Test

JumpCode Genomics Emerges From Stealth Mode With CRISPR-Based Library Prep Kits

Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable

Japanese Startup BitBiome Builds Single-Cell Bacterial Sequencing Services Business

Genetron Health, DMed Enter Pharma Services Partnership

Sponsorships